Type 2 Diabetes in Children and Adolescents on Atypical Antipsychotics
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Type 2 Diabetes in Children and Adolescents on Atypical Antipsychotics
Authors
Keywords
Antipsychotics, Children and adolescents, Diabetes, Obesity, Psychosis, Serious mental illness
Journal
Current Diabetes Reports
Volume 15, Issue 8, Pages -
Publisher
Springer Nature
Online
2015-06-17
DOI
10.1007/s11892-015-0623-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The STRIDE Weight Loss and Lifestyle Intervention for Individuals Taking Antipsychotic Medications: A Randomized Trial
- (2015) Carla A. Green et al. AMERICAN JOURNAL OF PSYCHIATRY
- 11. Children and Adolescents
- (2014) DIABETES CARE
- Trends in Smoking Among Adults With Mental Illness and Association Between Mental Health Treatment and Smoking Cessation
- (2014) Benjamin Lê Cook et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacologic and Behavioral Interventions to Improve Cardiovascular Risk Factors in Adults With Serious Mental Illness
- (2014) Jennifer M. Gierisch et al. JOURNAL OF CLINICAL PSYCHIATRY
- Quetiapine Treatment in Youth Is Associated With Decreased Insulin Secretion
- (2014) Ying Fai Ngai et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Risk of Diabetes in Children and Adolescents Exposed to Antipsychotics: A Nationwide 12-Year Case-Control Study
- (2014) René Ernst Nielsen et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Diabetes mellitus and severe mental illness: mechanisms and clinical implications
- (2014) Richard I. G. Holt et al. Nature Reviews Endocrinology
- Pharmacological Strategies to Counteract Antipsychotic-Induced Weight Gain and Metabolic Adverse Effects in Schizophrenia: A Systematic Review and Meta-analysis
- (2014) Y. Mizuno et al. SCHIZOPHRENIA BULLETIN
- Molecular pathophysiology of metabolic effects of antipsychotic medications
- (2014) Jacob S. Ballon et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Antipsychotic Induced Weight Gain: Genetics, Epigenetics, and Biomarkers Reviewed
- (2014) Tahireh A. Shams et al. Current Psychiatry Reports
- Cardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disorders
- (2014) Christoph U. Correll et al. JAMA Psychiatry
- Antipsychotic-Induced Insulin Resistance and Postprandial Hormonal Dysregulation Independent of Weight Gain or Psychiatric Disease
- (2013) Karen L. Teff et al. DIABETES
- The effects of antipsychotic switching on diabetes in chronic schizophrenia
- (2013) R. Arnoldy et al. DIABETIC MEDICINE
- A Behavioral Weight-Loss Intervention in Persons with Serious Mental Illness
- (2013) Gail L. Daumit et al. NEW ENGLAND JOURNAL OF MEDICINE
- Quantitative relationship between body weight gain in adulthood and incident type 2 diabetes: a meta-analysis
- (2013) S. Kodama et al. Obesity Reviews
- Management of Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) in Children and Adolescents
- (2013) K. C. Copeland et al. PEDIATRICS
- Genetics of antipsychotic-induced weight gain: update and current perspectives
- (2013) Amy CC Kao et al. PHARMACOGENOMICS
- Behavioral Interventions for Antipsychotic Induced Appetite Changes
- (2013) Ursula Werneke et al. Current Psychiatry Reports
- Antipsychotics and the Risk of Type 2 Diabetes Mellitus in Children and Youth
- (2013) William V. Bobo et al. JAMA Psychiatry
- Considering metformin in cardiometabolic protection in psychosis
- (2012) J. Curtis et al. ACTA PSYCHIATRICA SCANDINAVICA
- National Trends in the Office-Based Treatment of Children, Adolescents, and Adults With Antipsychotics
- (2012) Mark Olfson et al. ARCHIVES OF GENERAL PSYCHIATRY
- Body Weight and Metabolic Adverse Effects of Asenapine, Iloperidone, Lurasidone and Paliperidone in the Treatment of Schizophrenia and Bipolar Disorder
- (2012) Marc De Hert et al. CNS DRUGS
- The heart of the matter: cardiometabolic care in youth with psychosis
- (2012) Jackie Curtis et al. Early Intervention in Psychiatry
- Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone
- (2012) Peter Manu et al. SCHIZOPHRENIA RESEARCH
- Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation
- (2011) M. De Hert et al. BRITISH JOURNAL OF PSYCHIATRY
- Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice
- (2011) M. De Hert et al. EUROPEAN PSYCHIATRY
- Efficacy of metformin for prevention of weight gain in psychiatric populations
- (2011) Hannah Newall et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Prediabetes in Patients Treated With Antipsychotic Drugs
- (2011) Peter Manu et al. JOURNAL OF CLINICAL PSYCHIATRY
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
- (2011) Marc De Hert et al. Nature Reviews Endocrinology
- Antipsychotic Medication Use Among Children and Risk of Diabetes Mellitus
- (2011) S. E. Andrade et al. PEDIATRICS
- Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices
- (2011) A. J. Mitchell et al. PSYCHOLOGICAL MEDICINE
- Metabolic syndrome with the atypical antipsychotics
- (2011) Pornpoj Pramyothin et al. Current Opinion in Endocrinology Diabetes and Obesity
- Twenty-five year mortality of a community cohort with schizophrenia
- (2010) Steve Brown et al. BRITISH JOURNAL OF PSYCHIATRY
- From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics
- (2010) C.U. Correll EUROPEAN PSYCHIATRY
- Metformin for obesity and glucose dysregulation in patients with schizophrenia receiving antipsychotic drugs
- (2010) Mehrul Hasnain et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Review: Inequalities in healthcare provision for people with severe mental illness
- (2010) David Lawrence et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Increased Food Intake and Energy Expenditure Following Administration of Olanzapine to Healthy Men
- (2010) Robert J. Fountaine et al. Obesity
- Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis
- (2010) Christine Rummel-Kluge et al. SCHIZOPHRENIA RESEARCH
- Rethinking the genetic basis for comorbidity of schizophrenia and type 2 diabetes
- (2010) P.I. Lin et al. SCHIZOPHRENIA RESEARCH
- Obesity Among Those with Mental Disorders
- (2009) David B. Allison et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies
- (2009) Alex J. Mitchell et al. BRITISH JOURNAL OF PSYCHIATRY
- Obesity, serious mental illness and antipsychotic drugs
- (2009) Richard I. G. Holt et al. DIABETES OBESITY & METABOLISM
- How can antipsychotics cause diabetes mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins
- (2009) F.C.J. Starrenburg et al. EUROPEAN PSYCHIATRY
- Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)
- (2009) M. De Hert et al. EUROPEAN PSYCHIATRY
- Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors
- (2009) Amy M. Kilbourne et al. GENERAL HOSPITAL PSYCHIATRY
- Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
- (2009) Christoph U. Correll JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antipsychotics and Diabetes: An Age-Related Association
- (2008) Ariel Hammerman et al. ANNALS OF PHARMACOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now